EUROPLASMA

Bruges, France

EUROPLASMA

Bruges, France
SEARCH FILTERS
Time filter
Source Type

Au cœur des problématiques environnementales, EUROPLASMA conçoit et développe des solutions plasma innovantes destinées à la production d'énergies renouvelables et à la valorisation des déchets dangereux ainsi qu'à des applications connexes vers des industries multisectorielles soucieuses de réduire leur empreinte environnementale. L'action EUROPLASMA est cotée sur Alternext (FR0000044810-ALEUP). Pour plus d'informations: www.europlasma.com Ce communiqué contient des informations et déclarations de nature prévisionnelle fondées sur les meilleures estimations de la Direction à la date de leur publication. Ces informations sont soumises par nature à des risques et incertitudes difficilement prévisibles et généralement en dehors du champ d'action du Groupe. Ces risques incluent les risques listés dans le Document du Référence du Groupe disponible sur son site internet http://www.europlasma.com. Les performances futures du Groupe peuvent en conséquence différer sensiblement des informations prospectives communiquées et le Groupe ne peut prendre aucun engagement quant à la réalisation de ces éléments prévisionnels.


Au cœur des problématiques environnementales, EUROPLASMA conçoit et développe des solutions plasma innovantes destinées à la production d'énergies renouvelables et à la valorisation des déchets dangereux ainsi qu'à des applications connexes vers des industries multisectorielles soucieuses de réduire leur empreinte environnementale. L'action EUROPLASMA est cotée sur Alternext (FR0000044810-ALEUP). Pour plus d'informations: www.europlasma.com


News Article | July 24, 2017
Site: www.prnewswire.co.uk

Europlasma announces the commercial delivery to Shanghai Kaineng New Technology Co, Ltd (KNC) of the fly ash vitrification unit of Houjie incinerator (China). The contract, signed inJanuary 2015, concerned the supply of engineering and equipment for a vitrication unit for fly ash from municipal solid waste (MSW) incineration. In this context, Europlasma Industries designed the vitrification furnace, which has been built by KNC,and supplied a 2MW plasma system (plasma torch and auxiliaries). This equipment had been successfully tested by end of 2016. The handover of the vitrification unit has been pronounced, without reserves, upon successful performance tests. In particular, the unit reached its maximal capacity over 24 hours by treating 1,450 kg/hour of fly ash, corresponding to 35 tons/day. Fly ash generated by MSW incineration is a highly toxic waste. Produced in massive quantities, it constitutes a major challenge in China, both for the environment and for public health. In 2015, 3.2 million of tons of fly ash have been generated, including 300,000 tons in the Beijing-Tianjin-Hebei province alone. Given the urgency of the situation, the Chinese government and public authorities realized the necessity to set up industrial long-term solutions to turn this hazardous waste into inert and re-usable material. The objective is ambitious, as treating 3.2 million tons of fly ash would require over 300 units of KNC's size. Cai Zhiliang, Chairman of Board of Director of Shanghai Kaineng New Technology Co, Ltd (KNC) welcomes the success of the contract : "In the past 3 years, we have been working with Europlasma successfully, professionals from both companies are working together very closely, not only being our good supplier but also Europlasma is a good friend who is leading us to have this opportunity to share the advantages of this hi technology. Today we are very proud to complete the first treatment facility in China with plasma technology from Europlasma. Our facility now has the capacity to treat 35 tons per day of fly ash for our power plant, this is a project which is highly encouraged by the local people and government. At this very moment, I would like to press my deep appreciation to KNC and Europlasma technician who were working hardly in our facility, they have exchanged and complemented each other technically, and have overcame many technical problems. We KNC would like to introduce Europlasma to our friends in the industry in China, to let more people sharing this great technology" Jean-Eric Petit, CEO of Europlasma group, déclares : "I warmly congratulate the KNC leaders and their teams for the quality of our collaboration which allowed the successful implementation of this technological first in China. We are now ready to leverage this success and develop new partnerships to meet the expectations of the Chinese depollution market." At the heart of environmental issues, Europlasma designs and develops innovative plasma solutions for renewable energy generation and hazardous waste recovery, as well as related applications for multi-sector companies wishing to reduce their environmental footprint. Europlasma is listed on Alternext (FR0000044810-ALEUP). For more information: www.europlasma.com This is a disclosure announcement from PR Newswire.


News Article | June 15, 2017
Site: www.prnewswire.co.uk

The minutes of the Shareholders' Meeting and quorum information are available on the Company's website, www.europlasma.com. EUROPLASMA informs its shareholders that the adjourned Ordinary and Extraordinary Annual General Meetings will be held on June 29, 2017 at 11 am in Pessac (33600) Cité de la Photonique - Bâtiment Sirah, 3-5, Allée des Lumières. For this second invitation, the quorum necessary for the approval of the resolutions of the Extraordinary General Meeting is 20% of the share capital. The notice of second invitation will be published in the Bulletin des Annonces Légales Obligatoires (BALO) as well as in a newspaper of legal announcements on June 19, 2017. Details on participating and voting in this General Assembly are outlined in these two notices. Documents and information relating to this Meeting are available to shareholders and can be consulted on the Company's website at: according to the applicable legal and regulatory provisions. In the case of postal voting, the terms and conditions are specified at the end of the meeting notice. Pierre Catlin, Chairman, states: "With the Final Acceptance of CHO Morcenx, Europlasma has taken a decisive step towards materializing the Group's development potential. Europlasma needs, more than ever, the mobilization of all its shareholders to deploy its growth projects and shape its future. I rely on your attendance at the General Meeting of June 29, 2017 in person or by proxy." At the heart of environmental issues, Europlasma designs and develops innovative plasma solutions for renewable energy generation and hazardous waste recovery, as well as related applications for multi-sector companies wishing to reduce their environmental footprint. Europlasma is listed on Alternext (FR0000044810-ALEUP). For more information: www.europlasma.com This is a disclosure announcement from PR Newswire.


News Article | June 15, 2017
Site: www.prnewswire.com

Les documents et renseignements relatifs à cette Assemblée sont tenus à la disposition des actionnaires et peuvent être consultés sur le site Internet de la Société à l'adresse : http://www.europlasma.com/fr/espace-actionnaires/assemblees-generales.html selon les dispositions légales et réglementaires applicables. Ce communiqué contient des informations et déclarations de nature prévisionnelle fondées sur les meilleures estimations de la Direction à la date de leur publication. Ces informations sont soumises par nature à des risques et incertitudes difficilement prévisibles et généralement en dehors du champ d'action du Groupe. Ces risques incluent les risques listés dans le Document du Référence du Groupe disponible sur son site internet http://www.europlasma.com. Les performances futures du Groupe peuvent en conséquence différer sensiblement des informations prospectives communiquées et le Groupe ne peut prendre aucun engagement quant à la réalisation de ces éléments prévisionnels.


News Article | June 14, 2017
Site: www.prnewswire.co.uk

This is a key milestone for the plant and for all upcoming CHO Power projects: 1.  Securing FA demonstrates the plant's ability to produce electricity on a commercial scale at its nominal capacity of 10MWe. As this development phase has been completed, CHO Morcenx is now entering its commercial production phase. The teams will now be able to maximize the long-term economic profitability of the plant in accordance with an optimization plan, which includes adjusting standard operating procedures for commercial operations. 2. Given CHO Morcenx is the world's first plant of its type operating at a commercial scale, CHO Power can now capitalize on this success to deploy its pipeline of new projects. 3. The revenues generated by CHO Morcenx's electricity generation should benefit the Europlasma Group's cash position, thus encouraging the growth of its other business activities. In November 2015, the FAR (Final Acceptance with Reserves) confirmed the plant's capacity to produce synthetic gas in sufficient quantity and quality to generate 10 MWe of renewable electricity. These reserves concerned the necessary improvements to the environmental and aesthetic standards of the site installation, as well as the new engines and their optimal operation alongside the turbine: Following the FA milestone, the Europlasma Group will implement in the coming months an active value-creation strategy for CHO Morcenx, the development of CHO Power pipeline, and the various other key projects carried out by the Group. Jean-Eric Petit, Managing Director of Europlasma, said: "Today marks a major milestone in the history of our Group. Having led Europlasma for over three years, I am very proud of the achievement of this FA and wish to congratulate and associate our teams to this success. Now that CHO Morcenx is able to operate at its nominal capacity, we will continue to improve its power and maximize the profitability of this new type of power plant. This success gives our plasma technology significant development prospects, both for CHO Power and for the other subsidiaries of the Group ". At the heart of environmental issues, Europlasma designs and develops innovative plasma solutions for renewable energy generation and hazardous waste recovery, as well as related applications for multi-sector companies wishing to reduce their environmental footprint. Europlasma is listed on Alternext (FR0000044810-ALEUP). For more information: www.europlasma.com This is a disclosure announcement from PR Newswire.


EUROPLASMA (ALEUP, ISIN FR 0000044810), concepteur et exploitant de solutions plasma pour la production d'énergies renouvelables et la valorisation des déchets dangereux, déclare le nombre total de droits de vote et d'actions composant son capital social au 31 mai 2017, conformément aux articles L. 233-8 II du code de commerce et 223-16 du règlement général de l'Autorité des marchés financiers,


Au cœur des problématiques environnementales, EUROPLASMA conçoit et développe des solutions plasma innovantes destinées à la production d'énergies renouvelables et à la valorisation des déchets dangereux ainsi qu'à des applications connexes vers des industries multisectorielles soucieuses de réduire leur empreinte environnementale. L'action EUROPLASMA est cotée sur Alternext (FR0000044810-ALEUP). Pour plus d'informations: www.europlasma.com


Patent
Europlasma | Date: 2012-02-08

Treating a synthesis gas includes generating a plasma jet from a non-transferred arc torch having a main axis, the jet having a propagation axis substantially collinear with the torch main axis. The plasma torch is mounted on a feed enclosure. The syngas is received at an inlet port of the feed enclosure, downstream from the plasma torch and feeding the syngas so the flow encounters the plasma jet to mix the syngas and plasma jet in a distribution chamber. The mixture is propagated in a reactor downstream from the feed enclosure to convert the syngas into an outlet gas. The reactor is in communication in its upstream portion with the feed enclosure through a flared segment, and has a longitudinal axis that is substantially collinear with the propagation axis of the plasma jet. The outlet gas is extracted via an outlet port and particles are captured by a submerged conveyor.


News Article | February 20, 2017
Site: www.prnewswire.co.uk

Suite à la remise en route de la centrale CHO Morcenx le 21 janvier 2017, après la réalisation des travaux d'optimisation, le protocole d'essais de réception du premier moteur Jenbacher s'est conclu avec succès le 18 février. Devant le défi technique que représente cette innovation majeure, le motoriste et les équipes de CHO Power ont communément décidé de soumettre le moteur à des tests de mise en service extrêmement exigeants qui ont duré plusieurs semaines. Conformément au protocole de réception, incluant en particulier un essai  de 48 heures, le moteur a délivré sa puissance minimale garantie (1,5 MWe) avec une fiabilité de 100 %. Cette phase de tests a également permis de valider l'entière compatibilité du moteur au gaz de synthèse produit par la centrale CHO Morcenx à partir de la gazéification de Combustibles Solides de Récupération (CSR) et de biomasse. Elle a enfin permis de valider le fonctionnement simultané du moteur à gaz et de la turbine à vapeur. La prochaine étape consiste désormais à réceptionner le second moteur Jenbacher. Rigoureusement identique au premier, il bénéficiera directement de l'expérience acquise ces dernières semaines en termes de réglages et d'optimisations techniques. Au cœur des problématiques environnementales, EUROPLASMA conçoit et développe des solutions plasma innovantes destinées à la production d'énergies renouvelables et à la valorisation des déchets dangereux ainsi qu'à des applications connexes vers des industries multisectorielles soucieuses de réduire leur empreinte environnementale. L'action EUROPLASMA est cotée sur Alternext (FR0000044810-ALEUP). Pour plus d'informations: www.europlasma.com Ceci est un communiqué d'informations réglementaires diffusé par PR Newswire

Loading EUROPLASMA collaborators
Loading EUROPLASMA collaborators